CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 147 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $97 | -80.6% | 58,376 | -40.0% | 0.00% | – |
| Q1 2024 | $499 | -67.0% | 97,233 | -63.1% | 0.00% | -100.0% |
| Q4 2023 | $1,510 | +24.3% | 263,471 | +3.6% | 0.00% | 0.0% |
| Q3 2023 | $1,215 | +1477.9% | 254,231 | +1296.0% | 0.00% | – |
| Q2 2023 | $77 | -85.7% | 18,211 | -82.0% | 0.00% | – |
| Q1 2023 | $538 | -28.6% | 101,192 | -15.7% | 0.00% | – |
| Q4 2022 | $754 | -99.9% | 120,091 | +44.0% | 0.00% | -100.0% |
| Q3 2022 | $880,000 | +5766.7% | 83,401 | +2978.7% | 0.00% | – |
| Q2 2022 | $15,000 | -80.5% | 2,709 | -67.6% | 0.00% | – |
| Q1 2022 | $77,000 | – | 8,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |